Beijing Deep Glint Technology (688207.SH) appoints Wu Meng as Chief Financial Officer
Geling Shen Tong (688207.SH) announced that the company recently received a notice from its director and chief financial officer, Ms. Wang Yan...
Beijing Deep Glint Technology (688207.SH) announced that the company has recently received written resignation reports from the company's director and CFO, Ms. Wang Yan, and director Mr. Li Xinghua. Ms. Wang Yan has resigned from her positions as director, member of the board's strategic committee, and CFO for personal reasons. After her resignation, Ms. Wang Yan will no longer hold any positions in the company. Mr. Li Xinghua has resigned from his position as director and member of the board's audit committee for personal reasons. However, he will still hold other positions in the company and continue to serve as a core technical personnel.
On September 20, 2024, the company held its sixth meeting of the second session of the board of directors and approved the proposal to appoint Mr. Wu Meng as the company's CFO. Mr. Wu Meng's term will start from the date of approval by the board of directors until the end of the second session of the board of directors. The board's audit committee has also approved Mr. Wu Meng's appointment as CFO, and the board's nomination committee has reviewed and approved his qualifications.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025